Crinetics Pharmaceuticals Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 93
Employees
  • Stock Symbol
  • CRNX
Stock Symbol
  • Share Price
  • $20.93
  • (As of Thursday Closing)

Crinetics Pharmaceuticals General Information

Description

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidates include paltusotine which is in clinical development for the treatment of acromegaly and neuroendocrine tumors, or NETs, CRN04777, which is in clinical development for congenital hyperinsulinism, or HI, and CRN04894, which is in clinical development for diseases of excess adrenocorticotrophic hormone, or ACTH, including Cushing's Disease, congenital adrenal hyperplasia, or CAH, and Ectopic ACTH Syndrome, or EAS.

Contact Information

Website
www.crinetics.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 10222 Barnes Canyon Road
  • Building No. 2
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Crinetics Pharmaceuticals Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crinetics Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.93 $20.36 $13.83 - $28.95 $967M 47.5M 299K -$2.79

Crinetics Pharmaceuticals Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 629,481 281,944 481,804 551,215
Revenue 0 71 1,193 2,428
EBITDA (97,706) (73,855) (52,995) (28,392)
Net Income (98,488) (73,812) (50,422) (27,115)
Total Assets 209,359 183,445 130,377 171,415
Total Debt 3,322 4,014 4,849 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Crinetics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial

Crinetics Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial

Crinetics Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and comm
Drug Discovery
San Diego, CA
93 As of 2020
00000
000000000 00000

00000000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000 000000000
London, United Kingdom
000 As of 0000
00000
0000 0000-00-00
00000000 00000

0000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Cambridge, MA
0000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crinetics Pharmaceuticals Competitors (60)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Achilles Therapeutics Formerly VC-backed London, United Kingdom 000 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 000000000 00.000
00000000 Formerly VC-backed Tübingen, Germany 000 00000 000000000 00000
00 00000000 Venture Capital-Backed Irvine, CA 00 000.00 00000000000 000.00
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
You’re viewing 5 of 60 competitors. Get the full list »

Crinetics Pharmaceuticals Patents

  • 27

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Crinetics Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210047287-A1 Nonpeptide somatostatin type 5 receptor agonists and uses thereof Pending 14-Aug-2019 0000000000
EP-3853218-A1 Somatostatin modulators and uses thereof Pending 18-Sep-2018 0000000000
US-20200087318-A1 Somatostatin modulators and uses thereof Granted 18-Sep-2018 0000000000
US-10696689-B2 Somatostatin modulators and uses thereof Active 18-Sep-2018 0000000000
US-20200283453-A1 Somatostatin modulators and uses thereof Pending 18-Sep-2018 C07D498/04
To view Crinetics Pharmaceuticals’s complete patent history, request access »

Crinetics Pharmaceuticals Executive Team (9)

Name Title Board Seat Contact Info
Ajay Madan Ph.D Executive
Richard Struthers Ph.D Co-Founder, Chief Executive Officer & Board Member
Marc Wilson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Jeff Knight Chief Operating Officer, Operations
Adriana Cabré Vice President of Human Resources
You’re viewing 5 of 9 executive team members. Get the full list »

Crinetics Pharmaceuticals Board Members (12)

Name Representing Role Since
Camille Bedrosian MD Self Board Member 000 0000
David Allison Ph.D 5AM Ventures Board Observer 000 0000
Matthew Fust Self Board Member 000 0000
Richard Struthers Ph.D Crinetics Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Stephanie Okey Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Crinetics Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crinetics Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial